Literature DB >> 28839981

Mediastinal lymph node dissection: the debate is not resolved.

Jeffrey Shayani1, Raja M Flores1, Ardeshir Hakami1.   

Abstract

Year:  2017        PMID： 28839981      PMCID： PMC5542963          DOI： 10.21037/jtd.2017.06.128

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

1.  Video-assisted thoracoscopic surgery (VATS) lobectomy: catastrophic intraoperative complications.

Authors:  Raja M Flores; Ugonna Ihekweazu; Joseph Dycoco; Nabil P Rizk; Valerie W Rusch; Manjit S Bains; Robert J Downey; David Finley; Prasad Adusumilli; Inderpal Sarkaria; James Huang; Bernard Park
Journal:  J Thorac Cardiovasc Surg       Date:  2011-10-19       Impact factor: 5.209

2.  ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer.

Authors:  Didier Lardinois; Paul De Leyn; Paul Van Schil; Ramon Rami Porta; David Waller; Bernward Passlick; Marcin Zielinski; Toni Lerut; Walter Weder
Journal:  Eur J Cardiothorac Surg       Date:  2006-09-12       Impact factor: 4.191

3.  Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases - results of a preliminary study.

Authors:  B Passlick; B Kubuschock; W Sienel; O Thetter; K Pantel; J R Izbicki
Journal:  Eur J Cardiothorac Surg       Date:  2002-03       Impact factor: 4.191

4.  Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer.

Authors:  Mark Shapiro; Sagar Kadakia; James Lim; Andrew Breglio; Juan P Wisnivesky; Andrew Kaufman; Dong-Seok Lee; Raja M Flores
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

5.  Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis.

Authors:  H Asamura; H Nakayama; H Kondo; R Tsuchiya; T Naruke
Journal:  J Thorac Cardiovasc Surg       Date:  1999-06       Impact factor: 5.209

6.  Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter.

Authors:  K Sugi; K Nawata; N Fujita; K Ueda; T Tanaka; T Matsuoka; Y Kaneda; K Esato
Journal:  World J Surg       Date:  1998-03       Impact factor: 3.352

7.  Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

8.  Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.

Authors:  Andrea Bille; Kaitlin M Woo; Usman Ahmad; Nabil P Rizk; David R Jones
Journal:  Eur J Cardiothorac Surg       Date:  2017-04-01       Impact factor: 4.191

9.  N2 disease in T1 non-small cell lung cancer.

Authors:  Sebastian A Defranchi; Stephen D Cassivi; Francis C Nichols; Mark S Allen; K Robert Shen; Claude Deschamps; Dennis A Wigle
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

Review 10.  Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Xiongfeng Huang; Jianmin Wang; Qiao Chen; Jielin Jiang
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240
View more
  2 in total

1.  Is survival after sublobar resection vs. lobectomy made equivalent by extent of lymphadenectomy?

Authors:  Kimberly J Song; Raja M Flores
Journal:  Ann Transl Med       Date:  2019-09

2.  Pathologic N0 Status in Clinical T1N0M0 Lung Adenocarcinoma is Predictable by the Solid Component Proportion with Quantitative CT Number Analysis.

Authors:  Meng Li; Ning Wu; Li Zhang; Wei Sun; Jianwei Wang; Lv Lv; Jiansong Ren; Dongmei Lin
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.